Serious adverse events are rare when semaglutide is prescribed and monitored by a licensed healthcare provider, but you should report persistent nausea, severe abdominal pain, or signs of pancreatitis (upper abdominal pain radiating to the back) to your clinician immediately
Molecular weight and sequence identity should always be confirmed via mass spectrometry data included in the batch Certificate of Analysis
GLP-1-based therapies can lower total calorie intake substantially, and emerging reviews note that this can also reduce diet quality, protein intake, and hydration if patients are not intentional about how they eat
and has served on the speakers bureau of AstraZeneca, Boehringer Ingelheim, Eli Lilly, Menarini/Berlin Chemie, Merck, Sharp & Dohme, and NovoNordisk